Extrinsic Tooth Whitening Evaluation of a Whitening Toothpaste

February 19, 2026 updated by: Church & Dwight Company, Inc.

Six-Week Clinical Evaluation of a Toothpaste in Tooth Whitening Via Extrinsic Stain Removal

This randomized, examiner-blind, parallel-group clinical study evaluated the effectiveness of a whitening toothpaste compared with a control toothpaste in removing extrinsic tooth stain over six weeks of twice-daily unsupervised use. Adult subjects were assessed at baseline and after 7, 14, 28, and 42 days of product use using the Macpherson Modification of the Lobene Stain Index. Oral soft and hard tissues and subject-reported sensory responses were also evaluated throughout the study.

Study Overview

Detailed Description

This single-site, randomized, examiner-blind, two-cell parallel clinical trial enrolled adult subjects with qualifying extrinsic tooth stain. Following baseline assessments, subjects were randomized to either a test whitening dentifrice or a marketed control dentifrice. Subjects brushed twice daily for two minutes with their assigned toothpaste and toothbrush for 42 days. Extrinsic stain on the labial surfaces of the 12 anterior teeth was evaluated at baseline and at Days 7, 14, 28, and 42 using the Macpherson Modification of the Lobene Stain Index, assessing stain intensity, stain area, and total stain scores. Safety was monitored via oral soft and hard tissue examinations and subject-reported sensory assessments. Treatment comparisons were performed using ANCOVA with baseline scores as covariates.

Study Type

Interventional

Enrollment (Actual)

118

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Fort Wayne, Indiana, United States, 46825
        • Salus Research, Inc.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults 18-65 years in good general health
  • Mean MLSI score ≥1.5 on labial surfaces of at least 8 of 12 anterior teeth
  • Adequate oral hygiene and willingness to comply with study requirements
  • Dental prophylaxis within past 18 months but not within past 3 months
  • Willing to refrain from other whitening or oral care products during the study

Exclusion Criteria:

  • Significant medical conditions or oral pathology affecting assessments
  • History of adverse reactions to oral hygiene products
  • Orthodontic appliances or restorations interfering with stain assessment
  • Moderate or advanced periodontitis
  • Recent bleaching or whitening treatments
  • Pregnant or nursing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Test Toothpaste
Investigational whitening toothpaste evaluated for removal of extrinsic tooth stain over 42 days of use.
Whitening toothpaste used twice daily for two minutes per brushing for six weeks.
Other: Sodium Fluoride Control Dentifrice
Non-whitening toothpaste used twice daily for two minutes per brushing for six weeks.
Non-whitening toothpaste used twice daily for two minutes per brushing for six weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Extrinsic Tooth Stain (Total Stain Score)
Time Frame: Baseline to Day 42
Mean change in total extrinsic stain score measured on the labial surfaces of the 12 anterior teeth using the Macpherson Modification of the Lobene Stain Index, combining stain intensity and stain area scores.
Baseline to Day 42

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Stain Intensity and Stain Area Scores
Time Frame: Baseline to Days 7, 14, 28, and 42
Mean changes in stain intensity and stain area scores at each post-baseline time point.
Baseline to Days 7, 14, 28, and 42

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subject-Reported Whitening and Sensory Assessments
Time Frame: Baseline and Days 7, 14, 28, and 42
Subject-reported perceptions of whitening, mouthfeel, and sensory responses collected via questionnaires.
Baseline and Days 7, 14, 28, and 42

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Annahita Ghassemi, PhD, Church & Dwight, Inc.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 8, 2024

Primary Completion (Actual)

September 20, 2024

Study Completion (Actual)

September 20, 2024

Study Registration Dates

First Submitted

February 19, 2026

First Submitted That Met QC Criteria

February 19, 2026

First Posted (Actual)

February 24, 2026

Study Record Updates

Last Update Posted (Actual)

February 24, 2026

Last Update Submitted That Met QC Criteria

February 19, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The sponsor does not plan to share individual participant data. Aggregate results are reported, but no de-identified datasets will be made publicly available.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stain Removal Efficacy

Clinical Trials on Whitening Test Dentifrice (Code 826)

Subscribe